Table 5 Odds ratio and 95% CI of fatty liver at 3-year follow-up according to baseline hemoglobin quartiles

Women

n = 741

n = 793

n = 711

n = 664

Incidence (%)

237 (32.0)

274 (34.6)

271 (38.1)

260 (39.2)

Model 1

1 (Ref)

1.12 (0.91–1.39)

1.31 (1.05–1.63) ^*

1.37 (1.10–1.70) ^*

Model 2

1 (Ref)

1.13 (0.90–1.41)

1.33 (1.06–1.66) ^*

1.39 (1.10–1.75) ^*

Model 3

1 (Ref)

1.19 (0.92–1.54)

1.20 (0.92–1.57)

1.11 (0.84–1.46)

NAFLD

Q1 (< 150 g/L)

Q2 (150-157g/L)

Q3 (158-164g/L)

Q4 (≥165 g/L)

Men

n = 356

n = 388

n = 358

n = 331

Incidence (%)

98 (27.5)

119 (30.7)

123 (34.4)

119 (36.0)

Model 1

1 (Ref)

1.17 (0.85–1.60)

1.38 (1.00–1.90) ^*

1.48 (1.07–2.04) ^*

Model 2

1 (Ref)

1.15 (0.83–1.60)

1.29 (0.93–1.80)

1.40 (1.00–1.96) ^*

Model 3

1 (Ref)

0.92 (0.63–1.33)

0.78 (0.53–1.15)

0.90 (0.61–1.34)